214390 — Kyongbo Pharmaceutical Co Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapNeutral

Annual balance sheet for Kyongbo Pharmaceutical Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	20,983	4,290	6,348	4,477	4,128
Net Total Accounts Receivable
Net Total Receivables	52,727	47,909	50,799	56,858	52,311
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	138,192	111,166	116,326	135,902	151,941
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	90,100	95,677	93,919	96,073	99,852
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	253,239	236,979	240,545	266,305	283,887
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	93,764	88,814	95,569	118,261	132,660
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Funded Status
Total Liabilities	97,182	91,278	96,841	121,924	137,733
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	156,057	145,701	143,704	144,381	146,154
Total Liabilities & Shareholders' Equity	253,239	236,979	240,545	266,305	283,887
Total Common Shares Outstanding